How Data Is Reshaping The Future Of Clinical Trials

By Paul Upham, Head of Smart Devices at Roche / Genentech; Rachel Chasse, Digital Operations Lead at ABBVIE; and Nicole Latimer, CEO of Medrio

In the last five years, there has been a surge in technology adoption within clinical trials, resulting in more complex study designs and an unprecedented influx of data in the life sciences industry. This data influx holds the potential to significantly enhance patient care, expedite trial processes, and hasten the development of effective treatments.

However, at present, this abundance of data poses a significant challenge for researchers and study teams. In response to this, Paul Upham, Head of Smart Devices at Roche/Genentech, Rachel Chasse, Digital Operations Lead at ABBVIE, and Nicole Latimer, CEO of Medrio, joined forces to engage in a discussion exploring the current impact of technology and data in trials, the sources of this data, the ways clinical technology can enhance data quality, and improved strategies for data management in clinical research.

Gain comprehensive insights into how technology influences patients from this discussion and more by accessing the article below.